The structure and function of the glucagon-like peptide-1 receptor and its ligands

被引:211
|
作者
Donnelly, Dan [1 ]
机构
[1] Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England
关键词
GLP-1; GPCR; exendin-4; exenatide; liraglutide; diabetes; glucagon; insulin; VASOACTIVE-INTESTINAL-PEPTIDE; GUINEA-PIG PANCREAS; N-TERMINAL DOMAIN; GLP-1; 7-36; AMIDE; IN-VITRO; INSULIN-SECRETION; DISPERSED ACINI; EXTRACELLULAR DOMAIN; PARATHYROID-HORMONE; BIOLOGICAL-ACTIVITY;
D O I
10.1111/j.1476-5381.2011.01687.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glucagon-like peptide-1(7-36)amide (GLP-1) is a 30-residue peptide hormone released from intestinal L cells following nutrient consumption. It potentiates the glucose-induced secretion of insulin from pancreatic beta cells, increases insulin expression, inhibits beta-cell apoptosis, promotes beta-cell neogenesis, reduces glucagon secretion, delays gastric emptying, promotes satiety and increases peripheral glucose disposal. These multiple effects have generated a great deal of interest in the discovery of long-lasting agonists of the GLP-1 receptor (GLP-1R) in order to treat type 2 diabetes. This review article summarizes the literature regarding the discovery of GLP-1 and its physiological functions. The structure, function and sequenceactivity relationships of the hormone and its natural analogue exendin-4 (Ex4) are reviewed in detail. The current knowledge of the structure of GLP-1R, a Family B GPCR, is summarized and discussed, before its known interactions with the principle peptide ligands are described and summarized. Finally, progress in discovering non-peptide ligands of GLP-1R is reviewed. GLP-1 is clearly an important hormone linking nutrient consumption with blood sugar control, and therefore knowledge of its structure, function and mechanism of action is of great importance.
引用
收藏
页码:27 / 41
页数:15
相关论文
共 50 条
  • [21] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05) : 788 - 805
  • [22] Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands
    Wootten, Denise
    Savage, Emilia E.
    Willard, Francis S.
    Bueno, Ana B.
    Sloop, Kyle W.
    Christopoulos, Arthur
    Sexton, Patrick M.
    MOLECULAR PHARMACOLOGY, 2013, 83 (04) : 822 - 834
  • [23] The potential of glucagon-like peptide-1 receptor agonists in heart failure
    Kreiner, Frederik Flindt
    Hovingh, G. Kees Kornelis
    von Scholten, Bernt Johan
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [24] Metabolic responses and benefits of glucagon-like peptide-1 (GLP-1) receptor ligands
    Tanday, Neil
    Flatt, Peter R.
    Irwin, Nigel
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 526 - 541
  • [25] Glucagon-like peptide-1 receptor expression and its functions are regulated by androgen
    Zhu, Liying
    Zhou, Jinxing
    Pan, Yu
    Lv, Jing
    Liu, Yang
    Yu, Shanhe
    Zhang, Yifan
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 120
  • [26] Glucagon-like peptide-1 receptor agonists and safety in the preconception period
    Minis, Evelyn
    Stanford, Fatima Cody
    Mahalingaiah, Shruthi
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2023, 30 (06) : 273 - 279
  • [27] Association of Perioperative Glucagon-like Peptide-1 Receptor Agonist Use and Postoperative Outcomes
    Aschen, Seth Z.
    Zhang, Ashley
    O'Connell, Gillian M.
    Salingaros, Sophia
    Andy, Caroline
    Rohde, Christine H.
    Spector, Jason A.
    ANNALS OF SURGERY, 2025, 281 (04) : 600 - 607
  • [29] Glucagon-like peptide-1 receptor agonist stimulates mitochondrial bioenergetics in human adipocytes
    Goralska, Joanna
    Sliwa, Agnieszka
    Gruca, Anna
    Razny, Urszula
    Chojnacka, Monika
    Polus, Anna
    Solnica, Bogdan
    Malczewska-Malec, Malgorzata
    ACTA BIOCHIMICA POLONICA, 2017, 64 (03) : 423 - 429
  • [30] Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease
    Hong, Chien-Tai
    Chen, Jia-Hung
    Hu, Chaur-Jong
    JOURNAL OF BIOMEDICAL SCIENCE, 2024, 31 (01)